151 related articles for article (PubMed ID: 32897879)
1. PPP2R2D suppresses IL-2 production and Treg function.
Pan W; Sharabi A; Ferretti A; Zhang Y; Burbano C; Yoshida N; Tsokos MG; Tsokos GC
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897879
[TBL] [Abstract][Full Text] [Related]
2. PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
Pan W; Scherlinger M; Yoshida N; Tsokos MG; Tsokos GC
J Immunol; 2022 Aug; 209(3):621-628. PubMed ID: 35831019
[TBL] [Abstract][Full Text] [Related]
3. The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.
Pan W; Nagpal K; Suárez-Fueyo A; Ferretti A; Yoshida N; Tsokos MG; Tsokos GC
J Immunol; 2021 Apr; 206(8):1719-1728. PubMed ID: 33762326
[TBL] [Abstract][Full Text] [Related]
4. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y
Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966
[TBL] [Abstract][Full Text] [Related]
5. Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.
Crispín JC; Apostolidis SA; Finnell MI; Tsokos GC
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12443-8. PubMed ID: 21746932
[TBL] [Abstract][Full Text] [Related]
6. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
Front Immunol; 2019; 10():2606. PubMed ID: 31781109
[TBL] [Abstract][Full Text] [Related]
7. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
[TBL] [Abstract][Full Text] [Related]
8. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
9. The serine/threonine protein phosphatase 2A controls autoimmunity.
Sharabi A; Kasper IR; Tsokos GC
Clin Immunol; 2018 Jan; 186():38-42. PubMed ID: 28736280
[TBL] [Abstract][Full Text] [Related]
10. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.
Joseph BK; Liu HY; Francisco J; Pandya D; Donigan M; Gallo-Ebert C; Giordano C; Bata A; Nickels JT
J Biol Chem; 2015 Apr; 290(17):10588-98. PubMed ID: 25694423
[TBL] [Abstract][Full Text] [Related]
12. How GRAIL controls Treg function to maintain self-tolerance.
Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
[TBL] [Abstract][Full Text] [Related]
13. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
14. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.
Juang YT; Rauen T; Wang Y; Ichinose K; Benedyk K; Tenbrock K; Tsokos GC
J Biol Chem; 2011 Jan; 286(3):1795-801. PubMed ID: 21097497
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.
Crispín JC; Apostolidis SA; Rosetti F; Keszei M; Wang N; Terhorst C; Mayadas TN; Tsokos GC
J Immunol; 2012 Apr; 188(8):3567-71. PubMed ID: 22422882
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells in systemic lupus erythematosus.
Ohl K; Tenbrock K
Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
[TBL] [Abstract][Full Text] [Related]
18. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
Ding Y; Yu A; Tsokos GC; Malek TR
J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.
Katsiari CG; Kyttaris VC; Juang YT; Tsokos GC
J Clin Invest; 2005 Nov; 115(11):3193-204. PubMed ID: 16224536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
